semaglutide blue cross Alberta 2026 Pipeline: GLP-1 'Second Wave' Coming Excellus BlueCross BlueShield updates GLP-1

The most common issues

Being overweight or obese is a serious health problem connected with some leading causes of death, including diabetes, stroke, and heart disease, and is associated with an increased risk of certain types of cancer

Some people are deferred because their diabetes is not stable at the time of donation

Front Behav Neurosci

Retrieved 8 April 2024

GSM-directed therapy in peri/postmenopausal patients (or others with hypo-oestrogen states): NICE and UK resources support vaginal oestrogen as a local therapy for genitourinary symptoms of menopause, with patient counselling that systemic absorption is minimal and serious adverse effects are very rare